Outcomes of adding induction chemotherapy to concurrent chemoradiotherapy for stage T3N0-1 nasopharyngeal carcinoma: a propensity-matched study

OBJECTIVE: Our objective was to examine whether adding induction chemotherapy to concurrent chemoradiotherapy improved survival in stage III nasopharyngeal carcinoma (NPC) patients, especially in low-risk patients at stage T3N0-1. MATERIALS AND METHODS: We retrospectively analyzed 687 patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Lan, Xiao-Wen, Xiao, Yao, Zou, Xue-Bin, Zhang, Xiao-Min, OuYang, Pu-Yun, Xie, Fang-Yun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5546817/
https://www.ncbi.nlm.nih.gov/pubmed/28814884
http://dx.doi.org/10.2147/OTT.S133917

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5546817/
https://www.ncbi.nlm.nih.gov/pubmed/28814884
http://dx.doi.org/10.2147/OTT.S133917

Ejemplares similares